196 related articles for article (PubMed ID: 23020808)
21. KML001 cytotoxic activity is associated with its binding to telomeric sequences and telomere erosion in prostate cancer cells.
Phatak P; Dai F; Butler M; Nandakumar MP; Gutierrez PL; Edelman MJ; Hendriks H; Burger AM
Clin Cancer Res; 2008 Jul; 14(14):4593-602. PubMed ID: 18628474
[TBL] [Abstract][Full Text] [Related]
22. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
[TBL] [Abstract][Full Text] [Related]
23. Short telomere length, cancer survival, and cancer risk in 47102 individuals.
Weischer M; Nordestgaard BG; Cawthon RM; Freiberg JJ; Tybjærg-Hansen A; Bojesen SE
J Natl Cancer Inst; 2013 Apr; 105(7):459-68. PubMed ID: 23468462
[TBL] [Abstract][Full Text] [Related]
24. Telomere length is a biomarker of cumulative oxidative stress, biologic age, and an independent predictor of survival and therapeutic treatment requirement associated with smoking behavior.
Babizhayev MA; Savel'yeva EL; Moskvina SN; Yegorov YE
Am J Ther; 2011 Nov; 18(6):e209-26. PubMed ID: 20228673
[TBL] [Abstract][Full Text] [Related]
25. Telomere dysfunction: a potential cancer predisposition factor.
Wu X; Amos CI; Zhu Y; Zhao H; Grossman BH; Shay JW; Luo S; Hong WK; Spitz MR
J Natl Cancer Inst; 2003 Aug; 95(16):1211-8. PubMed ID: 12928346
[TBL] [Abstract][Full Text] [Related]
26. Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial.
Heaphy CM; Gaonkar G; Peskoe SB; Joshu CE; De Marzo AM; Lucia MS; Goodman PJ; Lippman SM; Thompson IM; Platz EA; Meeker AK
Prostate; 2015 Aug; 75(11):1160-6. PubMed ID: 25893825
[TBL] [Abstract][Full Text] [Related]
27. Telomere length variation and maintenance in hepatocarcinogenesis.
Yokota T; Suda T; Igarashi M; Kuroiwa T; Waguri N; Kawai H; Mita Y; Aoyagi Y
Cancer; 2003 Jul; 98(1):110-8. PubMed ID: 12833463
[TBL] [Abstract][Full Text] [Related]
28. Aging-associated alteration of telomere length and subtelomeric status in female patients with Parkinson's disease.
Maeda T; Guan JZ; Koyanagi M; Higuchi Y; Makino N
J Neurogenet; 2012 Jun; 26(2):245-51. PubMed ID: 22364520
[TBL] [Abstract][Full Text] [Related]
29. Aging-related alterations of subtelomeric methylation in sarcoidosis patients.
Maeda T; Guan JZ; Higuchi Y; Oyama J; Makino N
J Gerontol A Biol Sci Med Sci; 2009 Jul; 64(7):752-60. PubMed ID: 19414507
[TBL] [Abstract][Full Text] [Related]
30. Reduced telomere length variation in healthy oldest old.
Halaschek-Wiener J; Vulto I; Fornika D; Collins J; Connors JM; Le ND; Lansdorp PM; Brooks-Wilson A
Mech Ageing Dev; 2008 Nov; 129(11):638-41. PubMed ID: 18765247
[TBL] [Abstract][Full Text] [Related]
31. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
[TBL] [Abstract][Full Text] [Related]
32. Short leukocyte telomere length is associated with abdominal aortic aneurysm (AAA).
Atturu G; Brouilette S; Samani NJ; London NJ; Sayers RD; Bown MJ
Eur J Vasc Endovasc Surg; 2010 May; 39(5):559-64. PubMed ID: 20172749
[TBL] [Abstract][Full Text] [Related]
33. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788
[TBL] [Abstract][Full Text] [Related]
34. [Proton beam therapy].
Ogino T
Gan To Kagaku Ryoho; 2006 Apr; 33(4):450-4. PubMed ID: 16612152
[TBL] [Abstract][Full Text] [Related]
35. Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma.
Plentz RR; Schlegelberger B; Flemming P; Gebel M; Kreipe H; Manns MP; Rudolph KL; Wilkens L
Hepatology; 2005 Sep; 42(3):522-6. PubMed ID: 16116624
[TBL] [Abstract][Full Text] [Related]
36. Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy.
Corriveau J; Wallner K; Merrick G; True L; Cavanagh W; Sutlief S; Butler W
Brachytherapy; 2003; 2(2):108-13. PubMed ID: 15062149
[TBL] [Abstract][Full Text] [Related]
37. Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells.
Joshu CE; Peskoe SB; Heaphy CM; Kenfield SA; Van Blarigan EL; Mucci LA; Giovannucci EL; Stampfer MJ; Yoon G; Lee TK; Hicks JL; De Marzo AM; Meeker AK; Platz EA
Cancer Prev Res (Phila); 2015 Aug; 8(8):737-42. PubMed ID: 25990087
[TBL] [Abstract][Full Text] [Related]
38. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
39. Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer.
Kyas I; Hof H; Debus J; Schlegel W; Karger CP
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):768-74. PubMed ID: 17097829
[TBL] [Abstract][Full Text] [Related]
40. To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy.
Valdagni R; Rancati T; Ghilotti M; Cozzarini C; Vavassori V; Fellin G; Fiorino C; Girelli G; Barra S; Zaffaroni N; Pierotti MA; Gariboldi M
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1431-40. PubMed ID: 19211196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
